Clinical Trials

Study Title:
A012301: LoTam: A Randomized, Phase III Clinical Trial of LowDose Tamoxifen for Selected Patients with Molecular Low-risk EarlyStage Breast Cancer

For more information about the trial above please contact the study team:

Lexington Medical Center
Affiliate Principal Investigator, Madden, Steven, at samadden@lexhealth.org.

Medical University of South Carolina
Principal Investigator, Sivapiragasam, Abirami, at sivapira@musc.edu.
Study Coordinator, Gelardi, Theresa, at gelardi@musc.edu.

Self Regional Medical Center
Affiliate Principal Investigator, Metzner-Sadurski, Joanna, at jsadurski@selfregional.org.
Study Coordinator, Blalock, Margaret, at margaret.bentley@selfregional.org.

Trial opened at the following institutions: Lexington Medical Center, Self Regional Medical Center, Medical University of South Carolina